Dual-Modal Imaging and Synergistic Spinal Tumor Therapy Enabled by Hierarchical-Structured Nanofibers with Cascade Release and Postoperative Anti-adhesion

ACS Nano. 2022 Oct 25;16(10):16880-16897. doi: 10.1021/acsnano.2c06848. Epub 2022 Sep 22.

Abstract

Most treatments for spinal cancer are accompanied by serious side effects including subsequent tumor recurrence, spinal cord compression, and tissue adhesion, thus a highly effective treatment is crucial for preserving spinal and neurological functionalities. Herein, trilayered electrospun doxorubicin@bovine serum albumin/poly(ε-caprolactone)/manganese dioxide (DOX@BSA/PCL/MnO2) nanofibers with excellent antiadhesion ability, dual glutathione/hydrogen peroxide (GSH/H2O2) responsiveness, and cascade release of Mn2+/DOX was fabricated for realizing an efficient spinal tumor therapy. In detail, Fenton-like reactions between MnO2 in the fibers outermost layer and intra-/extracellular glutathione within tumors promoted the first-order release of Mn2+. Then, sustained release of DOX from the fibers' core layer occurred along with the infiltration of degradation fluid. Such release behavior avoided toxic side effects of drugs, regulated inflammatory tumor microenvironment, amplified tumor elimination efficiency through synergistic chemo-/chemodynamic therapies, and inhibited recurrence of spinal tumors. More interestingly, magnetic resonance and photoacoustic dual-modal imaging enabled visualizations of tumor therapy and material degradation in vivo, achieving rapid pathological analysis and diagnosis. On the whole, such versatile hierarchical-structured nanofibers provided a reference for rapid and potent theranostic of spinal cancer in future clinical translations.

Keywords: cascade release; dual-modal imaging; hierarchical-structured nanofibers; postoperative antiadhesion; spinal tumor therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Delayed-Action Preparations
  • Doxorubicin / pharmacology
  • Doxorubicin / therapeutic use
  • Glutathione / metabolism
  • Humans
  • Hydrogen Peroxide
  • Manganese Compounds / pharmacology
  • Nanofibers*
  • Nanoparticles*
  • Neoplasms* / therapy
  • Oxides
  • Serum Albumin, Bovine
  • Spinal Neoplasms* / drug therapy
  • Tissue Adhesions / drug therapy
  • Tumor Microenvironment

Substances

  • Manganese Compounds
  • Hydrogen Peroxide
  • Serum Albumin, Bovine
  • Oxides
  • Delayed-Action Preparations
  • Doxorubicin
  • Glutathione